Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study is a prospective, open label, two-arm, randomized multicenter trial to evaluate
the efficacy and safety of aspirin plus prasugrel as compared with aspirin plus clopidogrel
in patients undergoing elective percutaneous coronary intervention with drug eluting stents
for complex coronary lesions.
Phase:
Phase 4
Details
Lead Sponsor:
Samsung Medical Center
Collaborators:
Chonnam National University Hospital Chung-Ang University Hosptial, Chung-Ang University College of Medicine Chungbuk National University Hospital Chungnam National University Hospital Dankook University Ewha Womans University Ewha Womans University Seoul Hospital Gachon University Gil Medical Center Gyeongsang National University Hospital Incheon St.Mary's Hospital Inje University Keimyung University Dongsan Medical Center Konkuk University Chungju Hospital Mediplex Sejong Hospital Sejong General Hospital Seoul St. Mary's Hospital Soonchunhyang University Hospital Wonju Severance Christian Hospital Wonkwang University Hospital Yeungnam University Hospital